During the past decade, McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 36 clinical trials were completed, i.e. on average, 450% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 10 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center" #1 sponsor was "Radiation Therapy Oncology Group" with 18 trials, followed by "Eastern Cooperative Oncology Group" with 9 trials sponsored, "NSABP Foundation Inc" with 6 trials sponsored, "Gynecologic Oncology Group" with 5 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 45 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator and "SWOG Cancer Research Network" with 3 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center" are "Lung Cancer" (8 trials), "Breast Cancer" (6 trials), "Colorectal Cancer" (5 trials), "Prostate Cancer" (4 trials) and "Head and Neck Cancer" (3 trials). Many other conditions were trialed in "McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center" in a lesser frequency.

Most popular intervention types in "McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center" are "Drug" (43 trials), "Radiation" (23 trials), "Biological" (15 trials), "Other" (4 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "cetuximab" (7 trials), "Etoposide" (5 trials), "cisplatin" (5 trials), "Carboplatin" (3 trials) and "Cisplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center" are 42 trials for "All" genders, 11 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center". undefined are not yet recruiting, 5 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center, 3 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".